Tumors Sharply Increased after Ceasing Pazopanib Therapy for a Patient with Advanced Uterine Leiomyosarcoma: Experience of Tumor Flare

Pazopanib has activity in patients with soft-tissue sarcoma. We report an advanced uterine leiomyosarcoma case that suddenly worsened after cessation of pazopanib therapy. A 47-year-old woman had a primary uterine leiomyosarcoma tumor and multiple lung metastases, which progressed during her initial...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanigawa, Terumi, Morisaki, Shintaro, Fukuda, Hisanobu, Yoshimura, Shuichiro, Nakajima, Hisayoshi, Kotera, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397618/
https://www.ncbi.nlm.nih.gov/pubmed/28484655
http://dx.doi.org/10.1155/2017/4801650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397618/
https://www.ncbi.nlm.nih.gov/pubmed/28484655
http://dx.doi.org/10.1155/2017/4801650

Ejemplares similares